MiNK Therapeutics
INKT
INKT
21 hedge funds and large institutions have $565K invested in MiNK Therapeutics in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
Holders
21
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$955 | |
| 2 | +$258 | |
| 3 | +$172 | |
| 4 |
JPMorgan Chase & Co
New York
|
+$138 |
| 5 |
BlackRock
New York
|
+$105 |
Top Sellers
| 1 | -$11.5K | |
| 2 | -$8.95K | |
| 3 | -$3.47K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$2.34K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$1.3K |